TITLE

Clinical digest. Initial test identifies men who will benefit from prostate cancer screening

PUB. DATE
April 2014
SOURCE
Nursing Standard;4/23/2014, Vol. 28 Issue 34, p17
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article discusses research in the article "Influence of Blood Prostate Specific Antigen Levels at Age 60 on Benefits and Harms of Prostate Cancer Screening: Population Based Cohort Study" by S. Carlsson et al., which appeared in a 2014 issue of the "British Medical Journal" and found a test which identifies men who will benefit from prostate cancer screening.
ACCESSION #
95684315

 

Related Articles

  • Abstract 18 -- PSA Screenings for Prostate Cancer: Current Status, Future Directions. Godley, Paul A. // Oncologist;Oct2012 Supplement, Vol. 17 Issue S2, p8 

    The article presents an abstract on the current status of prostate specific antigen (PSA) testing for prostate cancer.

  • Patient Information: Q: Should I have a PSA screening?  // JAAPA: Journal of the American Academy of Physician Assistants (;Jul2012, Vol. 25 Issue 7, p58 

    The article provides an answer to a question of whether a patient should have a Prostate Specific Antigen (PSA) screening test for prostate cancer detection.

  • The prostate-cancer test most men don't need.  // Consumer Reports on Health;Apr2015, Vol. 27 Issue 4, p6 

    The article discusses prostate cancer, its diagnosis and treatment options. Topics include the prostate specific antigen (PSA) blood test and non-endorsers U.S. Preventive Services Task Force and the American Cancer Society, and success and complications from screenings and treatments. It...

  • Rate of new prostate cancer diagnoses drops.  // Oncology Nurse Advisor;Jul/Aug2015, Vol. 6 Issue 4, p12 

    No abstract available.

  • 2012 - Periodic PSA-based screening in men 55 to 69 years of age reduced prostate cancer mortality. Hoffman, Richard M. // ACP Journal Club;7/17/2012, Vol. 157 Issue 2, p1 

    The article reports regular screening of prostate specific antigen (PSA) in blood serum of men between 55 to 69 years helps in early detection of prostate cancer. It mentions that cancer mortality is reduced only to a certain level by regular screening of PSA but with long term follow up of...

  • Controversial Cancer Screening Guidelines Can Help Nurses Start the Screening Conversation. Wujcik, Debra M. // ONS Connect;Aug2012, Vol. 27 Issue 8, p7 

    An introduction is presented in which the editor discusses various reports within the issue on topics including prostate cancer treatment, risks involved in prostate-specific antigen (PSA) tests and interviews with oncology nurses.

  • Prevention and Detection of Prostate Cancer. Ward-Smith, Peggy // Urologic Nursing;Jan/Feb2015, Vol. 35 Issue 1, p44 

    An abstract of the article "Prevention and Detection of Prostate Cancer" by R. F. Matshela, J. E. Maree and C. van Belkim is presented.

  • Prostate cancer screening and the management of clinically localized disease. Wilt, Timothy J.; Ahmed, Hashim U. // BMJ: British Medical Journal;2/2/2013, Vol. 346 Issue 7893, p28 

    Prostate cancer is an important health problem. More than 40 000 incident cases of prostate cancer and more than 10 000 prostate cancer related deaths occur each year in the United Kingdom. Prevention, detection, and treatment of localized prostate cancer remain controversial. Although screening...

  • When the Patient Asks: Q: Should I have a PSA screening? Hewett, Mary L. // JAAPA: Journal of the American Academy of Physician Assistants (;Jul2012, Vol. 25 Issue 7, p56 

    The article provides an answer to a question of whether a patient should have a Prostate Specific Antigen (PSA) screening test for prostate cancer detection.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics